Artificial Intelligence Screening on Patients With Primary Angle Closure Glaucoma
AI
1 other identifier
observational
1,500
1 country
1
Brief Summary
The Tomey CASIA (Tomey Corporation, Nagoya, Japan) is a novel rapid imaging device that captures high-quality imaging of the entire anterior chamber of the eye over detailed imaging of a single section. In this prospective study, we want to investigate and compare the anatomical structure of the drainage angle of the eye in patients with different types glaucoma using Tomey machine. This study gives us a better understanding of the predictability, validity and accuracy of Tomey machine in the diagnosis of different types of glaucoma. Moreover, the data collected here will be used to create an artificial intelligence (AI) platform to screen certain type of glaucoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2018
CompletedFirst Submitted
Initial submission to the registry
July 26, 2018
CompletedFirst Posted
Study publicly available on registry
August 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedAugust 2, 2018
July 1, 2018
1.8 years
July 26, 2018
July 26, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The accuracy of the CASIA 2 OCT
To compare the clinical applicability, accuracy, and validity of the CASIA 2 OCT (Tomey, Nagoya, Japan) in the assessment of anterior chamber angle of the eye in the glaucomatous patients withconventional imaging methods.
baseline
The sensitivity and specificity of the AI
To create an AI program to reliably screen patients with certain type of glaucoma (such as primary angle closure glaucoma, PACG) using images from CASIA 2 OCT. To test the sensitivity and specificity of the AI program to screen patients with glaucoma using images from CASIA 2 OCT. Another database comprised of CASIA 2 OCT images will be created and used to test the AI program. The diagnosis based on the AI program will be compared with diagnosis from glaucoma specialist.
baseline
Study Arms (3)
Normal
Patients without any type of glaucoma
Primary angle closure glaucoma
Patients with primary angle closure glaucoma
Primary open-angle glaucoma
Patients with primary open-angle glaucoma
Interventions
Using CASIA 2 OCT to assess the anterior chamber angle of the eye in the glaucomatous patients withconventional imaging methods
Eligibility Criteria
Outpatients ≥18 years old with or without glaucoma
You may qualify if:
- Patient with or without glaucoma
You may not qualify if:
- Patients with any history of eye surgery (except cataract surgery) including laser procedure.
- Age \< =18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sun Yat-sen Universitylead
- University of Californiacollaborator
Study Sites (1)
Zhognshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Haotian Lin, M.D,Ph.D
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
July 26, 2018
First Posted
August 2, 2018
Study Start
April 1, 2018
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
August 2, 2018
Record last verified: 2018-07